Search

Your search keyword '"Rivas‐Ruiz, Francisco"' showing total 524 results
Start Over Author "Rivas‐Ruiz, Francisco"
524 results on '"Rivas‐Ruiz, Francisco"'

3. Granulocyte and monocyte adsorptive apheresis (GMA) in patients with inflammatory bowel disease: A useful therapeutic tool not just in ulcerative colitis but also in Crohn's disease

Author

Fernández-Pérez, Francisco José, Fernández-Moreno, Nuria, Soria-López, Estela, Rodriguez-González, Francisco Javier, Fernández-Galeote, Francisco José, Lifante-Oliva, Ana, Ruíz-Hernández, Concepción, Escalante-Quijaite, Elisabeth, and Rivas-Ruiz, Francisco

Published
2024
Full Text
View/download PDF

13. Comparative Analysis of Therapeutic Showers and Bathtubs for Pain Management and Labor Outcomes—A Retrospective Cohort Study.

Author

Mellado-García, Elena, Díaz-Rodríguez, Lourdes, Cortés-Martín, Jonathan, Sánchez-García, Juan Carlos, Piqueras-Sola, Beatriz, Macías, Juan Carlos Higuero, Rivas Ruiz, Francisco, and Rodríguez-Blanque, Raquel

Subjects
ANALGESIA, OBSTETRICAL analgesia, FETAL heart rate, PAIN management, LABOR pain (Obstetrics), BATHTUBS, LABOR (Obstetrics), FIRST stage of labor (Obstetrics)
Abstract

Hydrotherapy, including the use of therapeutic showers and bathtubs, has been studied for its potential benefits in labor pain management. Previous research has indicated that hydrotherapy can alleviate pain, but comparative studies between therapeutic showers and bathtubs are scarce. Objective: This study aims to compare the effects of therapeutic showers and bathtubs on pain perception, labor duration, use of epidural analgesia, and maternal and neonatal outcomes during labor. Methods: A total of 124 pregnant women were included in this study. Participants were divided into two groups: those who used a therapeutic shower and those who used a bathtub during labor. Pain levels were measured using a visual analog scale (VAS). Labor duration, use of epidural analgesia, types of delivery, maternal outcomes (postpartum hemorrhage, perineal status, maternal hypotension, fever, and breastfeeding), and neonatal outcomes (APGAR scores, fetal heart rate, complications, and neonatal unit admissions) were recorded and analyzed. Results: Both the therapeutic shower and the bathtub effectively reduced pain perception, with the bathtub showing a greater reduction in VAS scores. The therapeutic shower group experienced a significantly shorter labor duration compared to the bathtub group. The majority of participants in both groups did not require epidural analgesia, with no significant differences between the groups. There were no significant differences in the types of delivery. Maternal outcomes indicated a lower incidence of perineal tears and episiotomies in the therapeutic shower group. Neonatal outcomes, including APGAR scores and fetal heart rate, were similar between the groups, with no significant differences in complications or neonatal unit admissions. Conclusions: Both therapeutic showers and bathtubs are effective for pain relief during labor, with the bathtub showing a higher reduction in pain intensity. The therapeutic shower is associated with a shorter labor duration and a lower incidence of perineal tears and episiotomies. Both methods are safe for neonatal well-being, making hydrotherapy a viable non-pharmacological option for pain management in labor. However, the therapeutic shower may offer additional benefits in terms of labor duration and maternal outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Biological and prognostic differences between symptomatic colorectal carcinomas and those detected by screening

Author

Quintana Lopez, José María, Mañas, Marisa Baré, Bautista, Maximino Redondo, Pérez de la Blanca, Eduardo Briones, Fernández de Larrea Baz, Nerea, Eizaguirre, Cristina Sarasqueta, Martínez, Antonio Escobar, Ruiz, Francisco Rivas, Morales-Suárez-Varela, María M., Blasco Amaro, Juan Antonio, Gonzalez, Isabel del Cura, Madariaga, Inmaculada Arostegui, González, Amaia Bilbao, Hernandez, Nerea González, García-Gutiérrez, Susana, Guerrero, Iratxe Lafuente, Larracoechea, Urko Aguirre, Calzada, Miren Orive, Corral, Josune Martin, Anton-Ladislao, Ane, Torà, Nuria, Pont, Marina, Martínez del Prado, María Purificación, Totorikaguena, Alberto Loizate, Estevez, Ignacio Zabalza, Alustiza, José Errasti, Gimeno García, Antonio Z., Aramburu, Santiago Lázaro, Serrano, Mercè Comas, Enríquez Navascues, José María, Galan, Carlos Placer, Perales, Amaia, Valmaña, Iñaki Urkidi, Erro Azkárate, José María, Lizarribar, Enrique Cormenzana, Muñoa, Adelaida Lacasta, Pibernat, Pep Piera, Cuevas, Elena Campano, Sotelo Gómez, Ana Isabel, Abril, Segundo Gómez, Medina-Cano, F., Alcaide, Julia, Del Rey-Moreno, Arturo, Alcántara, Manuel Jesús, Campo, Rafael, Casalots, Alex, Pericay, Carles, Gil, María José, Pera, Miquel, Collera, Pablo, Espinàs, Josep Alfons, Martínez, Mercedes, Espallargues, Mireia, Almazán, Caridad, Lindenbaum, Paula Dujovne, Fernández-Cebrián, José María, Fernández, Rocío Anula, Mayol Martínez, Julio Ángel, Cid, Ramón Cantero, Labajo, Héctor Guadalajara, Garceau, María Heras, Olmo, Damián García, Montalvo, Mariel Morey, Mar, Javier, Téllez, Teresa, Abitei, Cristina, Padilla-Ruiz, María del Carmen, Rivas-Ruiz, Francisco, Fúnez, Rafael, Pereda, Teresa, Rodrigo, Isabel, Baré, María Luisa, Morales Suárez-Varela, María Manuela, Zabalza, Iñaki, Sánchez del Charco, Matilde, Borrero Martín, Juan José, García del Moral, Raimundo, Escobar, Antonio, Quintana, José María, Aguirre, Urko, and Redondo, Maximino

Published
2019
Full Text
View/download PDF

36. Ultraviolet exposure of competitors during a Tokyo Olympic Sailing Regatta Test Event.

Author

Gutiérrez‐Manzanedo, José Vicente, Vaz Pardal, Carmen, Blázquez‐Sánchez, Nuria, De Gálvez, Maria Victoria, Aguilera‐Arjona, José, González‐Montesinos, Jose Luis, Rivas Ruiz, Francisco, and De Troya‐Martín, Magdalena

Subjects
SUNSHINE, REGATTAS, SKIN cancer, ULTRAVIOLET radiation, SPORTS teams, SAILING, SOLAR ultraviolet radiation
Abstract

Background: Overexposure to sunlight is the main cause of skin cancer. Photoprotection practices and sunburn play a crucial role in skin cancer prevention. Objectives: This study aimed to quantify the risk of sun exposure and to evaluate photoprotection practices in Spanish sailors during Olympic competitions. Methods: Solar daily ultraviolet (UV) radiation cycle, personal UV dosimetry, photoprotection practices and sunburn checking were followed during three consecutive days of competition among sailors from the Spanish Olympic Sailing Team during a Tokyo Olympic Regatta Test Event. Results: A total of 13 sailors (7 women), with mean age of 27.6 ± 4.7 years and sports experience of 17.7 ± 5.4 years, were studied. The most common phototypes were type III (53.8%) and type II (38.5%). The rate of sunburn checked was high (46.2%). The mean daily personal UV exposure received was 761.0 ± 263.6 J/m2, 3.0 ± 1.1 minimal erythemal dose and 7.6 ± 2.6 standard erythemal dose, seven times greater than the maximum permissible UV light exposure values for an 8 h working day. The use of a T‐shirt was the most common practice (94.2%), followed by the use of shade (50.2%), hat/cap (44.0%), sunglasses (26.1%) and sunscreen (11.8%). Conclusions: Olympic sailor's studies presented high levels of UV radiation received, high rate of sunburn and insufficient adherence to sun‐protective behaviours (especially, to use of sunscreen) to prevent sunburn, the main cause of skin cancer. Sport Federations should develop educational campaigns addressing sun‐related exposure habits and photoprotection behaviours to reduce the risk of skin cancer among these athletes. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

38. Prevalence and Influence on Prognosis of Mental Health Comorbidities in Long-term Breast Cancer Survivors: Results From the Surbcan Study

Author

Padilla-Ruiz, María, primary, Gimeno-Miguel, Antonio, additional, Rivas-Ruiz, Francisco, additional, Martínez-Casanova, Mª Carmen, additional, Jansana, Anna, additional, Prados-Torres, Alexandra, additional, Poblador-Plou, Beatriz, additional, Cura, Isabel Del, additional, Sanz-Cuesta, Teresa, additional, Ibáñez, Berta, additional, Castells, Xavier, additional, Sala, María, additional, and Redondo, Maximino, additional

Published
2022
Full Text
View/download PDF

46. Influence of depression on survival of colorectal cancer patients drawn from a large prospective cohort.

Author

Varela‐Moreno, Esperanza, Rivas‐Ruiz, Francisco, Padilla‐Ruiz, María, Alcaide‐García, Julia, Zarcos‐Pedrinaci, Irene, Téllez, Teresa, Fernández‐de Larrea‐Baz, Nerea, Baré, Marisa, Bilbao, Amaia, Sarasqueta, Cristina, Morales‐Suárez‐Varela, María Manuela, Aguirre, Urko, Quintana, José María, Redondo, Maximino, Varela-Moreno, Esperanza, Rivas-Ruiz, Francisco, Padilla-Ruiz, María, Alcaide-García, Julia, Zarcos-Pedrinaci, Irene, and Larrea-Baz, Nerea Fernández-de

Subjects
*RESEARCH, *RESEARCH methodology, *EVALUATION research, *COLORECTAL cancer, *COMPARATIVE studies, *MENTAL depression, *RESEARCH funding, *LONGITUDINAL method, *PROPORTIONAL hazards models
Abstract

Objective: The prevalence of depressive symptoms immediately after the diagnosis of colorectal cancer (CRC) is high and has important implications both psychologically and on the course of the disease. The aim of this study is to analyse the association between depressive symptoms and CRC survival at 5 years after diagnosis.Methods: This multicentre, prospective, observational cohort study was conducted on a sample of 2602 patients with CRC who completed the Hospital Anxiety and Depression Scale (HADS-D) at 5 years of follow-up. Survival was analysed using the Kaplan-Meier method and Cox regression models.Results: According to our analysis, the prevalence of depressive symptoms after a CRC diagnosis was 23.8%. The Cox regression analysis identified depression as an independent risk factor for survival (HR = 1.47; 95% CI: 1.21-1.8), a finding which persisted after adjusting for sex (female: HR = 0.63; 95% CI: 0.51-0.76), age (>70 years: HR = 3.78; 95% CI: 1.94-7.36), need for help (yes: HR = 1.43; 95% CI: 1.17-1.74), provision of social assistance (yes: HR = 1.46; 95% CI: 1.16-1.82), tumour size (T3-T4: HR = 1.56; 95% CI: 1.22-1.99), nodule staging (N1-N2: HR = 2.46; 95% CI: 2.04-2.96), and diagnosis during a screening test (yes: HR = 0.71; 95% CI: 0.55-0.91).Conclusions: There is a high prevalence of depressive symptoms in patients diagnosed with CRC. These symptoms were negatively associated with the survival rate independently of other clinical variables. Therefore, patients diagnosed with CRC should be screened for depressive symptoms to ensure appropriate treatment can be provided. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

48. Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain

Author

Garcia de Lucas, Maria Dolores, Miramontes-González, Jose Pablo, Avilés-Bueno, Beatriz, Jiménez-Millán, Ana Isabel, Rivas-Ruiz, Francisco, and Pérez-Belmonte, Luis M

Subjects
Adult, Glycated Hemoglobin, HbA1c, real-world use, Endocrinology, Diabetes and Metabolism, Body Weight, Glucagon-Like Peptides, T2DM, Ambulatory Care Facilities, Diabetes Mellitus, Type 2, Spain, Humans, Hypoglycemic Agents, once-weekly semaglutide, Retrospective Studies
Abstract

ObjectivesTo investigate the use of once-weekly semaglutide in a real population of people with type 2 diabetes mellitus (T2DM) in three Spanish hospitals.MethodAn observational, retrospective and multicenter clinical study was designed that included 166 participants with T2DM, distinguishing between a group naïve to GLP-1RA (n=72) and another switching from another GLP-1RA (n=94), all managed in the outpatient clinical setting. The primary endpoint was the change in HbA1c from baseline to the end of the study. The secondary endpoints included changes in body weight and the proportion of people with T2DM, achieving HbA1c 5%.ResultsAfter 24 months of follow-up, the reductions in HbA1c were -0.91 ± 0.7% (pConclusionsIn routine clinical practice in Spain, the use of semaglutide once a week was associated with statistically significant and clinically relevant improvements in HbA1c and body weight in a wide range of adults with T2DM, without notable adverse effects, which supports real-world use.

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results